6533b85efe1ef96bd12bf3b8
RESEARCH PRODUCT
Parathyroid Hormone as a Novel Biomarker for Chronic Obstructive Pulmonary Disease: Korean National Health and Nutrition Examination Survey
Hye Kyeong ParkSung-soon LeeHyeon-kyoung KooJoo-hyun ParkHoon Jungsubject
AdultMalemedicine.medical_specialtyNational Health and Nutrition Examination Surveylcsh:MedicineParathyroid hormonePulmonary function testingPulmonary Disease Chronic ObstructiveFEV1/FVC ratioInternal medicineRepublic of KoreaVitamin D and neurologyHumansMedicineVitamin Dlcsh:ScienceLungAgedCOPDMultidisciplinarybusiness.industrylcsh:RMiddle AgedNutrition Surveysmedicine.diseaseRespiratory Function Testsrespiratory tract diseasesEndocrinologyParathyroid HormoneMultivariate AnalysisQuality of LifeBiomarker (medicine)lcsh:QFemalebusinessBody mass indexBiomarkersResearch Articledescription
Objective To understand and predict chronic obstructive pulmonary disease (COPD), a biomarker that reflects disease severity is needed. Research Design and Methods Data from 10269 adults aged over 40 years of age were retrieved from the Korea National Health and Nutrition Examination Survey (KNHANES), and 1302 patients met the criteria for COPD. The association between values of vitamin D and parathyroid hormone (PTH), and COPD severity including lung function and quality of life, were analyzed. Results In COPD patients, lung function was inversely related to PTH values (P = 0.02 for FVC [% predicted]; P < 0.001 for FEV1 [% predicted]); however, the association of lung function with vitamin D levels was not statistically significant in a multivariable analysis. Value of PTH was independently associated with EQ5D-index (P = 0.04), but vitamin D level showed no significant relationship with EQ5D-index (P = 0.59) or EQ5D-VAS (P = 0.81). Conclusions Elevation of PTH, unlike vitamin D, is independently associated with COPD severity, and may be a better biomarker for COPD.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2015-06-19 | PLOS ONE |